ES503985A0 - Un procedimiento para la preparacion de pirimidin-2-onas sustituidas - Google Patents

Un procedimiento para la preparacion de pirimidin-2-onas sustituidas

Info

Publication number
ES503985A0
ES503985A0 ES503985A ES503985A ES503985A0 ES 503985 A0 ES503985 A0 ES 503985A0 ES 503985 A ES503985 A ES 503985A ES 503985 A ES503985 A ES 503985A ES 503985 A0 ES503985 A0 ES 503985A0
Authority
ES
Spain
Prior art keywords
group
compounds
susceptible
phase
normal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES503985A
Other languages
English (en)
Other versions
ES8300750A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES8300750A1 publication Critical patent/ES8300750A1/es
Publication of ES503985A0 publication Critical patent/ES503985A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES503985A 1980-07-15 1981-07-15 Un procedimiento para la preparacion de pirimidin-2-onas sustituidas Granted ES503985A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8023083 1980-07-15

Publications (2)

Publication Number Publication Date
ES8300750A1 ES8300750A1 (es) 1982-11-01
ES503985A0 true ES503985A0 (es) 1982-11-01

Family

ID=10514776

Family Applications (1)

Application Number Title Priority Date Filing Date
ES503985A Granted ES503985A0 (es) 1980-07-15 1981-07-15 Un procedimiento para la preparacion de pirimidin-2-onas sustituidas

Country Status (12)

Country Link
US (1) US4650800A (es)
EP (1) EP0044705B1 (es)
JP (1) JPS5740483A (es)
AT (1) ATE10256T1 (es)
AU (1) AU7300281A (es)
CA (1) CA1159830A (es)
DE (1) DE3167186D1 (es)
DK (1) DK315381A (es)
ES (1) ES503985A0 (es)
NO (1) NO812432L (es)
NZ (1) NZ197715A (es)
ZA (1) ZA814843B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8420610D0 (en) * 1984-08-14 1984-09-19 Glaxo Group Ltd Chemical compounds
JPH0679095B2 (ja) * 1986-04-03 1994-10-05 旭硝子株式会社 プラスチツククラツド光伝送フアイバ−
RU2102985C1 (ru) * 1995-11-10 1998-01-27 Владимир Константинович Васильев Способ подавления гиперактивных клеток

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
ES498337A0 (es) * 1980-01-07 1982-06-01 Nyegaard & Co As Un procedimiento para la preparacion de 5-halo-pirimidin-2- onas

Also Published As

Publication number Publication date
DE3167186D1 (en) 1984-12-20
US4650800A (en) 1987-03-17
ZA814843B (en) 1983-02-23
ATE10256T1 (de) 1984-11-15
CA1159830A (en) 1984-01-03
EP0044705B1 (en) 1984-11-14
AU7300281A (en) 1982-01-21
DK315381A (da) 1982-01-16
ES8300750A1 (es) 1982-11-01
EP0044705A1 (en) 1982-01-27
NO812432L (no) 1982-01-18
NZ197715A (en) 1984-12-14
JPS5740483A (en) 1982-03-06

Similar Documents

Publication Publication Date Title
ES8103744A1 (es) Un metodo para la preparacion de derivados de ftalimidina
ES8100276A1 (es) Un procedimiento para la preparacion de nuevos derivados de-4-anilinoquinazolinas
ES8406440A1 (es) Procedimiento para preparar derivados de 2-amino-3-acilamino-6-bencilamino-piridina
ES503984A0 (es) Un procedimiento para la preparacion de pirimidin-2-onas sustituidas
ES519650A0 (es) Un procedimiento para obtener derivados de indanilbenzamida.
SE8102220L (sv) Anvendning av substituerade derivat av 4-fenyl-4-oxo-2-butensyra sasom lekemedel
ES532337A0 (es) Procedimiento para la preparacion de 6-aril-3 (2h)piridazinonas
ES509219A0 (es) "un procedimiento para la preparacion de 5-halopirimidin-2-onas".
SE7605819L (sv) Nya propargyl-2-fenylaminoimidazolin-(2), dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
DK315381A (da) Fremgangsmaade til fremstilling af substituerede pyrimidin-2-oner eller salte deraf
ES497105A0 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli nas-(2)sustituidas.
NO159596C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive indolderivater.
NO157214C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolcarboxylsyrederivater.
SE7609385L (sv) Foreningar med antidepressiv aktivitet
NO151465C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater og syreaddisjonssalter derav
ES8403130A1 (es) Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas.
ES8307798A1 (es) Un procedimiento para la preparacion de derivados de piperazilmetil-4-dibenzofuranona, o, dibenzofuranol.
ES8103047A1 (es) Procedimiento de preparacion de derivados aminoisoquinolinosasi como de sus sales de adicion acidas, farmaceuticamente aceptables y de sus derivados amonicos cuaternarios
IL61695A (en) 2-(2,6-dihalophenyl-amino)-and 2-(2-fluoro-6-trifluoromethyl-phenyl-amino)-2-imidazoline derivatives,their preparation and pharmaceutical compositions containing them
ES500108A0 (es) Procedimiento para preparar nuevas benzotiopirano (2,3-c)pi-ridinas